Physician profile
Desmar Walkes
NPI 1831138767
$3,683.28
in general payments reported to CMS, 2019-2025
20 companies · $1,469 in 2025
The $1,469 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $905 · 2020: $776 · 2021: $318 · 2022: $83.67 · 2024: $132 · 2025: $1,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,054 · Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,054.35 |
| Food and Beverage | $546.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,468.91 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $432.62 | 2019-2020 | |
| Novo Nordisk INC | $293.80 | 2019-2021 | |
| Glaxosmithkline, LLC. | $258.12 | 2019-2022 | |
| Abbott Laboratories | $144.33 | 2021-2024 | Proclaim |
| Mylan Specialty L.P. | $137.37 | 2019-2022 | |
| Allergan, INC. | $132.83 | 2020 | |
| Radius Health, INC. | $115.28 | 2019-2020 | |
| Lilly USA, LLC | $109.70 | 2019-2020 | |
| Amgen INC. | $108.78 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.07 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $90.29 | 2020 | |
| Abbvie INC. | $73.94 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.27 | 2019-2020 | |
| Astellas Pharma US INC | $39.06 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $32.72 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $27.88 | 2020 | |
| Medtronic Minimed, INC. | $22.36 | 2020 | |
| Corcept Therapeutics | $15.10 | 2024 | Korlym |
| Amarin Pharma, INC. | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desmar Walkes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.